IP AstraZeneca not held liable for additional healthcare costs on appeal – healthcare insurance company can’t claim damages for patent enforcement, at least not in this case 07/01/2022
IP, Life Sciences Onvoldoende serieuze dreiging van onrechtmatig handelen bij aanvraag van full label handelsvergunning 18/08/2021
IP Finally a green light for the start of the UPC – an analysis of the ruling by the Bundesverfassungsgericht and the remaining preparatory work 16/07/2021
COVID-19, IP, Life Sciences Het initiatiefwetsvoorstel dwanglicenties ter bescherming van de volksgezondheid is symboolwetgeving 18/02/2021
Dispute Resolution, IP Beperking van processtukken in hoger beroep onjuist en onacceptabel | 22 min 05/01/2021
COVID-19, Dispute Resolution, Life Sciences A vaccine for COVID 19 –risks and liabilities in international perspective 07/09/2020
COVID-19, IP, Life Sciences Inzet van dwanglicenties voor geneesmiddelen – wordt er een probleem opgelost? 10/07/2020
IP German Constitutional Court declares the vote on the ratification act of the UPC Agreement unconstitutional because of a lack of the required quorum 01/04/2020
IP Implications of CJEU ruling on Brexit withdrawal notification for the Unified Patent Court | 5 min 21/12/2018
